Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Biogen Inc. (BIIB) had Revenue of $9.84B for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$9.84B
Net Income	$1.16B
Cost of Goods Sold	$2.53B
Gross Profit	$7.30B
Operating Expenses	$8.22B
Operating Income	$1.61B
Non-Operating Income/Expense	$-315.50M
Pre-Tax Income	$1.30B
Normalized Pre-Tax Income	$1.30B
Income after Taxes	$1.16B
Income from Continuous Operations	$1.16B
Consolidated Net Income/Loss	$1.16B
Normalized Income after Taxes	$1.16B
EBIT	$1.61B
EBITDA	$2.14B
Weighted-Average Shares Outstanding (Basic)	144.70M
Weighted-Average Shares Outstanding (Diluted)	145.60M
Earnings per Share (EPS) (Basic)	$8.02
Earnings per Share (EPS) (Diluted)	$7.97
Balance Sheet Financials
Current Assets	$6.86B
Property, Plant, and Equipment	$3.31B
Long-Term Assets	$19.99B
Total Assets	$26.84B
Current Liabilities	$3.43B
Long-Term Debt	$6.79B
Long-Term Liabilities	$8.61B
Total Liabilities	$12.05B
Common Equity	$14.80B
Tangible Shareholders Equity	$217.20M
Shareholders Equity	$14.80B
Common Shares Outstanding	144.90M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.55B
Cash Flow from Investing Activities	$-4.10B
Cash Flow from Financial Activities	$149.30M
Beginning Cash	$3.42B
End Cash	$1.05B
Increase/Decrease in Cash	$-2.37B
Stock-Based Compensation	$264.20M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.00
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.31
Debt to Equity Ratio	0.47
Gross Margin	74.24%
Operating Margin	16.39%
EBIT Margin	16.39%
EBITDA Margin	21.74%
Pre-Tax Profit Margin	13.18%
Profit Margin	11.81%
Free Cash Flow	$1.27B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.37
Inventory Turnover	1.00
Receiveable Turnover	5.91
Days Sales in Receivables	61.75
Return on Equity	7.85%
Return on Tangible Equity	534.76%
Return on Assets	4.33%
Return on Investments	5.38%
Book Value Per Share	$102.14
Free Cash Flow per Share	$8.72
Operating Cash Flow per Share	$10.63

Data from Zacks Investment Research, Inc.